VR Logo

Sequent Scientific Ltd.


Healthcare | Drugs & Pharma

we think vacations are for wimps

39 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids;

Incorporated: 1985

Chairman: Gopakumar G Nair

Managing Director: Manish Gupta

Group: Sequent

Listing: NSE: SEQUENT, BSE: 512529

Headquarters: Thane, Maharashtra

Website: http://www.sequent.in/

Key Facts

Market cap: R 3,951.58 Cr

Revenue (TTM): R 1,211.49 Cr

Earnings (TTM): R 91.22 Cr

Cash: R 116.00 Cr

Total Debt: R 330.65 Cr

Promoters' ownership: 54.87%

Liquidity: High

52 Week range: R 51.70 - 162.75

Face value: R2.00

Shares outstanding: 24,83,70,995

10 Years Aggregate:

  • CFO: 268.31 Cr
  • EBITDA: 608.20 Cr
  • Net Profit: 344.55 Cr

Stock Performance

Time Period Sequent Scientific S&P BSE Healthcare S&P BSE Small Cap
YTD125.5147.718.50
1 month18.512.89-0.85
3 months73.3120.3017.68
1 Year110.9955.9111.42
3 Years10.8613.94-2.30
5 Years-4.942.386.36
10 Years19.8312.693.75
As on 28-Sep-2020
Year Sequent Scientific S&P BSE Small Cap S&P BSE Healthcare
20194.13-6.85-3.55
2018-30.98-23.41-5.89
2017-10.9959.640.49
2016-55.481.77-12.88
2015144.446.7615.06
2014156.0369.2447.43
2013-10.09-11.2322.55